MORMED: towards a multilingual social networking platform facilitating medicine 2.0

The broad adoption of Web 2.0 tools has signalled a new era of "Medicine 2.0" in the field of medical informatics. The support for collaboration within online communities and the sharing of information in social networks offers the opportunity for new communication channels among patients, medical experts, and researchers. This paper introduces MORMED, a novel multilingual social networking and content management platform that exemplifies the Medicine 2.0 paradigm, and aims to achieve knowledge commonality by promoting sociality, while also transcending language barriers through automated translation. The MORMED platform will be piloted in a community interested in the treatment of rare diseases (Lupus or Antiphospholipid Syndrome)

Encourage. Empowering People. Annual Report 2012

Peter Löscher, President of the Siemens Stiftung Board of Trustees, on behalf of the Board: Siemens Stiftung aims to contribute to positive changes in society with technical solutions, concrete concepts, and platforms for knowledge transfer. Cooperating with various stakeholders is a fundamental requirement for increasing the impact of its projects and anchoring them for the long term. For that reason, Siemens Stiftung seeks to cooperate with other foundations and non-governmental organizations as well as with government institutions, businesses, and the scientific community. Partnerships allow complementary approaches, skills, and resources to be bundled and sustainable programs to be developed. The previous fiscal year, in particular, delivers impressive examples of how such partnership models can increase the effectiveness of project work

Novartis and the United Nations Global Compact Initiative

The spirit of the Global Compact found fertile ground and has become an integral part of Novartis corporate strategy since the enterprise was formed by the merger of the two large Swiss pharmaceutical companies, Sandoz and Ciba, in 1996. Following a four-year concentration on economic consolidation and performance, Daniel Vasella (Chairman and CEO) signed the Global Compact. Together, productivity-based economic performance and a proactive approach to the expectations of society are envisioned as the key to long-term corporate success in the rapidly integrating global economic, political, and social environment of today’s large multinational corporation. This paper outlines the Novartis strategy and its implementation including the coalescing role of the Global Compact in the drive for sustainable corporate development. Following a review of extending corporate strategy to incorporate social concerns into the economic business model, the process of implementing the strategy will be assessed. In part three, specific examples of this strategic positioning will be outlined.http://deepblue.lib.umich.edu/bitstream/2027.42/39911/3/wp526.pd

Scenarios for Educational and Game Activities using Internet of Things Data

Raising awareness among young people and changing their behavior and habits concerning energy usage and the environment is key to achieving a sustainable planet. The goal to address the global climate problem requires informing the population on their roles in mitigation actions and adaptation of sustainable behaviors. Addressing climate change and achieve ambitious energy and climate targets requires a change in citizen behavior and consumption practices. IoT sensing and related scenario and practices, which address school children via discovery, gamification, and educational activities, are examined in this paper. Use of seawater sensors in STEM education, that has not previously been addressed, is included in these educational scenaria

New Hampshire University Research and Industry Plan: A Roadmap for Collaboration and Innovation

This University Research and Industry plan for New Hampshire is focused on accelerating innovation-led development in the state by partnering academia’s strengths with the state’s substantial base of existing and emerging advanced industries. These advanced industries are defined by their deep investment and connections to research and development and the high-quality jobs they generate across production, new product development and administrative positions involving skills in science, technology, engineering and math (STEM)

Novartis and the United Nations Global Compact Initiative

The spirit of the Global Compact found fertile ground and has become an integral part of Novartis corporate strategy since the enterprise was formed by the merger of the two large Swiss pharmaceutical companies, Sandoz and Ciba, in 1996. Following a four-year concentration on economic consolidation and performance, Daniel Vasella (Chairman and CEO) signed the Global Compact. Together, productivity-based economic performance and a proactive approach to the expectations of society are envisioned as the key to long-term corporate success in the rapidly integrating global economic, political, and social environment of today’s large multinational corporation. This paper outlines the Novartis strategy and its implementation including the coalescing role of the Global Compact in the drive for sustainable corporate development. Following a review of extending corporate strategy to incorporate social concerns into the economic business model, the process of implementing the strategy will be assessed. In part three, specific examples of this strategic positioning will be outlined.Novartis, Pharmaceutical Industry, UN Global Compact, Gleevec, Novartis Institute for Tropical Diseases

Private philanthropy or policy transfer? The transnational norms of the Open Society Institute

The Open Society Institute (OSI) is a private operating and grant-making foundation that serves as the hub of the Soros Foundations Network, a group of autonomous national foundations around the world. OSI is a mechanism for the international diffusion of expertise and ‘best practices’ to post-communist countries and other democratising nations. Focusing on the ‘soft’ ideational and normative policy transfer, the article highlights the engagement in governance that comes with OSI transnational policy partnerships

The Role of the Health Care Sector in Expanding Economic Opportunity

This report provides an overview and critical assessment of the ways in which multinational pharmaceutical companies currently participate in expanding economic opportunities in developing countries. As pharmaceutical companies become more involved in both business and philanthropic activities in developing countries, it will be important for each company to identify the best strategies available to it to create new economic opportunities and to leverage the benefits of activities already underway. While the primary focus of the industry is, and will most likely continue to be, on increasing access to health care, the potential for expanding economic opportunities through its activities should not be overlooked as a significant outcome. The analysis and case studies contained in the report highlight companies' contributions to economic opportunity expansion through job creation, training and capacity building, and shaping public policy. The report also offers recommendations for future work to increase economic opportunities. This paper is part of the Economic Opportunity Series published by the CSR Initiative at Harvard University Kennedy School